Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumors. [electronic resource]
Producer: 20121030Description: 117-27 p. digitalISSN:- 1423-0232
- Antineoplastic Agents -- therapeutic use
- Benzenesulfonates -- therapeutic use
- Cell Differentiation
- ErbB Receptors -- metabolism
- Everolimus
- Histone Deacetylases -- metabolism
- Humans
- Immunologic Factors -- therapeutic use
- Indazoles
- Indoles -- pharmacology
- Molecular Targeted Therapy -- methods
- Neuroendocrine Tumors -- drug therapy
- Niacinamide -- analogs & derivatives
- Pancreatic Neoplasms -- drug therapy
- Phenylurea Compounds
- Pyridines -- therapeutic use
- Pyrimidines -- therapeutic use
- Pyrroles -- pharmacology
- Receptors, Somatostatin -- metabolism
- Sirolimus -- analogs & derivatives
- Sorafenib
- Sulfonamides -- therapeutic use
- Sunitinib
- TOR Serine-Threonine Kinases -- antagonists & inhibitors
- Vascular Endothelial Growth Factor A -- metabolism
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.